101 related articles for article (PubMed ID: 575608)
21. Assay of tryptophan decarboxylase from Catharanthus roseus plant cell cultures by high-performance liquid chromatography.
Pennings EJ; Hegger I; van der Heijden R; Duine JA; Verpoorte R
Anal Biochem; 1987 Aug; 165(1):133-6. PubMed ID: 3688427
[TBL] [Abstract][Full Text] [Related]
22. Adaptation of the liquid cation exchange method for the assay of 3,4-dihydroxy-L-phenylalanine and 5-hydroxy-L-tryptophan decarboxylases in rat brain.
Vaccari A
Brain Res; 1976 Sep; 114(1):171-80. PubMed ID: 963543
[No Abstract] [Full Text] [Related]
23. A comparison of synaptophysin, chromogranin, and L-dopa decarboxylase as markers for neuroendocrine differentiation in lung cancer cell lines.
Jensen SM; Gazdar AF; Cuttitta F; Russell EK; Linnoila RI
Cancer Res; 1990 Sep; 50(18):6068-74. PubMed ID: 2168288
[TBL] [Abstract][Full Text] [Related]
24. Assay of tryptophan hydroxylase and aromatic L-amino acid decarboxylase based on rapid separation of the reaction product by high performance liquid chromatography.
Hasegawa H; Yanagisawa M; Ichiyama A
J Biochem; 1984 Jun; 95(6):1751-8. PubMed ID: 6432776
[TBL] [Abstract][Full Text] [Related]
25. Aromatic L-amino acid decarboxylase activity in central and peripheral tissues and serum of rats with L-DOPA and L-5-hydroxytryptophan as substrates.
Rahman MK; Nagatsu T; Kato T
Biochem Pharmacol; 1981 Mar; 30(6):645-9. PubMed ID: 7271902
[No Abstract] [Full Text] [Related]
26. Sensitive assay for determination of pyridoxal-5-phosphate in enzymes using high-performance liquid chromatography after derivatization with cyanide.
Naoi M; Ichinose H; Takahashi T; Nagatsu T
J Chromatogr; 1988 Dec; 434(1):209-14. PubMed ID: 3243815
[No Abstract] [Full Text] [Related]
27. Depletion of AADC activity in caudate nucleus and putamen of Parkinson's disease patients; implications for ongoing AAV2-AADC gene therapy trial.
Ciesielska A; Samaranch L; San Sebastian W; Dickson DW; Goldman S; Forsayeth J; Bankiewicz KS
PLoS One; 2017; 12(2):e0169965. PubMed ID: 28166239
[TBL] [Abstract][Full Text] [Related]
28. L-dopa as substrate for human duodenal catechol-O-methyltransferase and aromatic L-amino acid decarboxylase.
Schultz E
Biomed Chromatogr; 1990 Nov; 4(6):242-4. PubMed ID: 2289048
[TBL] [Abstract][Full Text] [Related]
29. Aromatic L-amino acid decarboxylase is present in serotonergic fibers of the striatum of the rat. A double-labeling immunofluorescence study.
Arai R; Karasawa N; Nagatsu I
Brain Res; 1996 Jan; 706(1):177-9. PubMed ID: 8720509
[TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical analysis of the cross-reaction of anti-rat histidine decarboxylase antibody with guinea-pig DOPA decarboxylase.
Taguchi Y; Watanabe T; Shiosaka S; Tohyama M; Wada H
Brain Res; 1985 Aug; 340(2):235-42. PubMed ID: 3896404
[TBL] [Abstract][Full Text] [Related]
31. Assays for amino acid decarboxylase enzymes using ion-exchange cartridges.
Heerze LD; Kang YJ; Palcic MM
Anal Biochem; 1990 Mar; 185(2):201-5. PubMed ID: 2339778
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of the holoenzyme content of aromatic L-amino acid decarboxylase in brain and liver tissues.
Kawasaki Y; Hayashi H; Hatakeyama K; Kagamiyama H
Biochem Biophys Res Commun; 1992 Aug; 186(3):1242-8. PubMed ID: 1510658
[TBL] [Abstract][Full Text] [Related]
33. Aromatic L-amino acid decarboxylase in rat corpus striatum: implications for action of L-dopa in parkinsonism.
Melamed E; Hefti F; Pettibone DJ; Liebman J; Wurtman RJ
Neurology; 1981 Jun; 31(6):651-5. PubMed ID: 7195482
[TBL] [Abstract][Full Text] [Related]
34. Use of radiolabeled monofluoromethyl-Dopa to define the subunit structure of human L-Dopa decarboxylase.
Maneckjee R; Baylin SB
Biochemistry; 1983 Dec; 22(26):6058-63. PubMed ID: 6661425
[TBL] [Abstract][Full Text] [Related]
35. Neuronal dopa decarboxylase.
Siow YL; Dakshinamurti K
Ann N Y Acad Sci; 1990; 585():173-88. PubMed ID: 2192610
[No Abstract] [Full Text] [Related]
36. [Aspects of long-term treatment with levodopa alone and levodopa combined with dopa decarboxylase inhibitors].
Cinca I; Serbănescu A; Tudorache B
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1982; 27(4):261-70. PubMed ID: 6222452
[No Abstract] [Full Text] [Related]
37. Evidence for PQQ as cofactor in 3,4-dihydroxyphenylalanine (dopa) decarboxylase of pig kidney.
Groen BW; van der Meer RA; Duine JA
FEBS Lett; 1988 Sep; 237(1-2):98-102. PubMed ID: 2844591
[TBL] [Abstract][Full Text] [Related]
38. Vesicular monoamine transporter-2 and aromatic L-amino acid decarboxylase gene therapy prevents development of motor complications in parkinsonian rats after chronic intermittent L-3,4-dihydroxyphenylalanine administration.
Lee WY; Lee EA; Jeon MY; Kang HY; Park YG
Exp Neurol; 2006 Jan; 197(1):215-24. PubMed ID: 16269145
[TBL] [Abstract][Full Text] [Related]
39. Mammalian histidine decarboxylase and dopa decarboxylase.
Wada H; Taketoshi M; Imamura I; Tanaka T; Horio Y; Taguchi Y; Fukui H
Ann N Y Acad Sci; 1990; 585():145-61. PubMed ID: 1694064
[No Abstract] [Full Text] [Related]
40. [Serum dopamine-beta-hydroxylase, glutamic acid decarboxylase and 1-aromatic amino acid decarboxylase in involuntary movement disorders (author's transl)].
Nakamura S; Miyata S; Kameyama M
Rinsho Shinkeigaku; 1979 Aug; 19(8):511-4. PubMed ID: 159153
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
